Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy, such as irinotecan, oxaliplatin, and capecitabine, work in
different ways to stop tumor cells from dividing so they stop growing or die. Combining more
than one chemotherapy drug may kill more tumor cells. This phase I trial is studying the side
effects and best dose of irinotecan, oxaliplatin, and capecitabine in treating patients with
unresectable solid tumors.